| scholarly article | Q13442814 |
| P50 | author | Dominique Schols | Q47698773 |
| Olivier Gevaert | Q56334002 | ||
| P2093 | author name string | T M D'Hooghe | |
| E Waelkens | |||
| K Peeraer | |||
| B De Moor | |||
| C Meuleman | |||
| C Tomassetti | |||
| D Popovic | |||
| D Huskens | |||
| A Mihalyi | |||
| X Bossuyt | |||
| A Kasran | |||
| A Bokor | |||
| A Fassbender | |||
| A Vodolazkaia | |||
| C M Kyama | |||
| Y El-Aalamat | |||
| P2860 | cites work | The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 |
| Peripheral biomarkers of endometriosis: a systematic review | Q24632541 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| Circadian rhythm of serum interleukin-6 in rheumatoid arthritis | Q33566549 | ||
| Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis | Q33676547 | ||
| Differences in characteristics among 1,000 women with endometriosis based on extent of disease | Q34129883 | ||
| Validation study of nonsurgical diagnosis of endometriosis. | Q34434954 | ||
| ESHRE guideline for the diagnosis and treatment of endometriosis | Q56627429 | ||
| Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis | Q58228805 | ||
| Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons | Q34544373 | ||
| Angiogenic factors in endometriosis. | Q34597482 | ||
| Glycodelin in reproductive endocrinology and hormone-related cancer | Q34657737 | ||
| A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis | Q35031005 | ||
| A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis | Q35203718 | ||
| Adhesions in patients with chronic pelvic pain: a role for adhesiolysis? | Q35979408 | ||
| Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications | Q36261408 | ||
| Support vector machines versus logistic regression: improving prospective performance in clinical decision-making | Q36484686 | ||
| Understanding diagnostic tests 3: Receiver operating characteristic curves | Q36765868 | ||
| Angiogenesis and antiangiogenic therapy in endometriosis | Q36851446 | ||
| Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries | Q36920902 | ||
| CA 125 secretion by peritoneal mesothelial cells | Q37248310 | ||
| Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory | Q37387924 | ||
| Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? | Q37636124 | ||
| Clinical management of endometriosis | Q37921069 | ||
| The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons | Q38441791 | ||
| Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis | Q38526444 | ||
| Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status | Q40189701 | ||
| Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial | Q40663036 | ||
| What do we know about the origin of CA 125? | Q40843228 | ||
| Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities | Q41619198 | ||
| Cyclic plasma IL-6 levels during normal menstrual cycle | Q42440048 | ||
| High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis | Q42485838 | ||
| Presurgical diagnosis of posterior deep infiltrating endometriosis based on a standardized questionnaire. | Q43317273 | ||
| Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1. | Q43423662 | ||
| Diagnostic delay in women with pain and endometriosis | Q43672377 | ||
| The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. | Q43783739 | ||
| High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners | Q44448852 | ||
| Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. | Q46036918 | ||
| Biomarkers of endometriosis | Q46534265 | ||
| Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions | Q47289724 | ||
| Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. | Q50683586 | ||
| Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. | Q51306439 | ||
| Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis. | Q51786953 | ||
| Panel of markers can accurately predict endometriosis in a subset of patients. | Q51907666 | ||
| IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. | Q54434488 | ||
| Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. | Q54504939 | ||
| Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. | Q54626498 | ||
| Revised American Society for Reproductive Medicine classification of endometriosis: 1996 | Q55933584 | ||
| Endometriosis | Q55951108 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| endometriosis | Q205764 | ||
| P304 | page(s) | 2698-2711 | |
| P577 | publication date | 2012-06-26 | |
| P1433 | published in | Human Reproduction | Q5937357 |
| P1476 | title | Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis | |
| P478 | volume | 27 |
| Q55329577 | A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update. |
| Q38235997 | Biomarker development in endometriosis |
| Q90113970 | Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives |
| Q28488305 | Biomarkers in reproductive medicine: the promise, and can it be fulfilled? |
| Q34406190 | Biomarkers in uterine leiomyoma |
| Q24185755 | Blood biomarkers for the non-invasive diagnosis of endometriosis |
| Q33756335 | CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics |
| Q61797208 | CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis |
| Q89530011 | Challenges in uncovering non-invasive biomarkers of endometriosis |
| Q28082378 | Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise |
| Q52912801 | Circulating miRNAs in Murine Experimental Endometriosis. |
| Q35562931 | Circulating microRNAs as potential biomarkers for endometriosis |
| Q26824289 | Clinical diagnosis of pelvic endometriosis: a scoping review |
| Q26823337 | Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France |
| Q30250332 | Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. |
| Q46059433 | Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. |
| Q58801981 | Diagnostic value of serum ICAM-1 for endometriosis: A meta-analysis |
| Q64069400 | Discovery of non-invasive biomarkers for the diagnosis of endometriosis |
| Q50433163 | Dysregulation of GdA Expression in Endometrium of Women With Endometriosis: Implication for Endometrial Receptivity |
| Q49584912 | Endometriosis: Epidemiology, Diagnosis and Clinical Management. |
| Q44067089 | Evaluation of elevated urinary enolase I levels in patients with endometriosis. |
| Q33888309 | Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis. |
| Q38141097 | Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. |
| Q44306353 | Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis |
| Q54537848 | Industry is Not the Dark Side, but an Essential Partner to Make Progress in Reproductive Health. |
| Q42369318 | Industry is not the dark side, but an essential partner to make progress in reproductive health |
| Q40743672 | Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis |
| Q36914684 | Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis - a targeted 'omics study |
| Q30409164 | Molecular classification of endometriosis and disease stage using high-dimensional genomic data |
| Q33987534 | Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation |
| Q38197676 | Noninvasive biomarkers of endometriosis: myth or reality? |
| Q51598512 | Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis. |
| Q92612447 | Plasma miRNAs as biomarkers for endometriosis |
| Q42280526 | Possibility of using superoxide dismutase and glutathione peroxidase as endometriosis biomarkers |
| Q92239350 | Raman spectroscopy as a non-invasive diagnostic technique for endometriosis |
| Q46565764 | Research Priorities for Endometriosis |
| Q38961304 | Serum markers for the noninvasive diagnosis of endometriosis |
| Q51026736 | Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons ( Papio anubis) With Experimentally-Induced Disease. |
| Q38883876 | Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. |
| Q34867890 | Somatic stem cells and their dysfunction in endometriosis |
| Q92715957 | Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis |
| Q28082175 | The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects |
| Q24564121 | The role of lipoxin A4 in endometrial biology and endometriosis |
| Q37280164 | The role of placental protein 14 in the pathogenesis of endometriosis |
| Q38124850 | Understanding the pathogenesis of endometriosis through proteomics: recent advances and future prospects |
| Q26799195 | Update on Biomarkers for the Detection of Endometriosis |
| Q90236302 | miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells |
Search more.